Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04393155 · ClinicalTrials.gov registry record
COVID Cohort Study
A clinical trial, sponsored by University of Vermont.
- Terminated
- Registry status
- 16
- Enrollment target
NCT04393155 is a clinical trial that was terminated before completion, run by University of Vermont. The registered enrollment target is 16 participants.
The verdict
NCT04393155 was terminated before completion, sponsored by University of Vermont.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The novel SARS-CoV-2 virus has quickly spread worldwide, with substantial morbidity and mortality. There is very limited understanding of the short- and longer-term inflammatory/immunological and clinical course. However, the investigators expect survivors from severe COVID-19 to experience persistent functional impairments, as demonstrated in prior studies of patients with acute respiratory distress syndrome (ARDS) and other acute viral illnesses. Notably, however, few studies have ever investigated the biologic mechanisms underlying these functional impairments. Understanding these features of COVID-19 will improve the ability to design acute therapies and recovery-focused interventions. To address these knowledge gaps, the investigators propose a two-center, 225 patient longitudinal prospective cohort study of hospitalized COVID-19 patients with acute respiratory failure. Researchers will perform an in-depth evaluation of inflammatory/immunological biomarkers, and physical, pulmonary, and neuropsychological clinical outcomes during hospitalization, and over 3-, 6-, and 12-month follow-up.
Interventions
- OTHER COVID-19+ observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-04-16 |
| Est. Completion | 2021-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04393155
The ClinicalTrials.gov registry entry for NCT04393155 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID-19+ observational is the first listed.
NCT04393155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04393155 about?
NCT04393155 is a clinical study titled "COVID Cohort Study". The novel SARS-CoV-2 virus has quickly spread worldwide, with substantial morbidity and mortality. There is very limited understanding of the short- and longer-term inflammatory/immunological and clinical course. However, the investigators expect survivors from severe COVID-19 to experience persiste...
What is the current status of trial NCT04393155?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2020-04-16. Estimated completion is 2021-01-25.
What interventions are being tested in trial NCT04393155?
The interventions under investigation include: COVID-19+ observational (OTHER).
Who is sponsoring clinical trial NCT04393155?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.